Cynthia M Molina

Title: Innovations of Cynthia M Molina

Introduction

Cynthia M Molina is a notable inventor based in Deerfield, IL (US). She has made significant contributions to the field of immunoassays, particularly in the detection of amphetamine-class analytes. With a total of 5 patents to her name, her work has advanced the methodologies used in clinical diagnostics.

Latest Patents

Cynthia's latest patents include innovative reagents, methods, and kits for an amphetamine-class fluorescence polarization immunoassay (FPIA). This immunoassay is designed to detect the presence of one or more amphetamine-class analytes in a test sample. The process involves competition between the analyte and a fluorescently labeled tracer for the binding site on an antibody specific for phenethylamine derivatives. The concentration of the amphetamine-class analyte in the sample determines the amount of tracer that binds to the antibody. The amount of tracer-antibody complex formed can be quantitatively measured and is inversely proportional to the quantity of analyte in the test sample. This invention relates to tracers, immunogens used to elicit antibodies for use as assay reagents, and assay kits incorporating these tracers and assay reagents.

Career Highlights

Cynthia M Molina is currently associated with Abbott Laboratories Corporation, where she continues to innovate in the field of diagnostics. Her work has been instrumental in developing advanced testing methods that enhance the accuracy and efficiency of clinical assessments.

Collaborations

Cynthia has collaborated with esteemed colleagues such as Paul J Brynes and Donald D Johnson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of immunoassays.

Conclusion

Cynthia M Molina's contributions to the field of immunoassays exemplify her dedication to innovation and excellence. Her patents and collaborations reflect her commitment to advancing diagnostic methodologies.